Abstract:Background: The rate of carbapenem-resistant Klebsiella pneumoniae (CRKP) infection has been increasing rapidly worldwide and, poses a significant risk to human health. Effective methods are urgently needed to address treatment failures related to antibiotic resistance. Recent research has reported that some drugs in combination with antibiotics have displayed synergistic killing of resistant bacteria. Here, we investigated whether glutathione (GSH) can synergize with meropenem, and enhance its effectiveness against CRKP. Methods: Synergistic activity was assessed by checkerboard and time-killing assays. The mechanism of these combinations was assessed by total ROS and membrane permeability assays. The bacterial metabolites were assessed by LC‒MS/MS. Results: The FICIs of GSH and meropenem were approximately 0.5 and the combined treatment with GSH and meropenem resulted in a more than 2log10 CFU/mL reduction in bacteria compared to the individual treatments. These findings indicated the synergistic effect of the two drugs. Moreover, the meropenem MIC of CRKP was reduced to less than 4 mg/L when combined with 6 mg/mL GSH, indicating that GSH could significantly reverse resistance to meropenem in bacteria. The production of ROS in bacteria was determined by flow cytometry. After adding GSH, the ROS in the GSH group and the combined group was significantly higher than that in the control and meropenem groups, but there was no significant difference between the combined and GSH groups. The metabolic disturbance caused by GSH alone and in combination with meropenem was significant intracellularly and extracellularly, especially in terms of glycerophospholipid metabolism, indicating that the synergistic effect of the combined use of GSH and meropenem was relevant to glycerophospholipid metabolism. In addition, we measured the cell membrane permeability. The cell membrane permeability of the combination group was significantly higher than that of the blank control or monotreatment groups. This confirmed that the GSH can serve as a meropenem enhancers by disturbing glycerophospholipid metabolism and increasing cell membrane permeability. Conclusion: GSH and meropenem display a synergistic effect, wherein GSH increases the sensitivity of CRKP to meropenem. The synergy and susceptibility effects are thought to related to the increased membrane permeability resulting from the perturbations in glycerophospholipid metabolism, presenting a novel avenue for CRKP treatment.

Oxidized glutathione reverts carbapenem resistance in blaNDM-1-carrying Escherichia coli

Dissemination of bla NDM-5 gene via an IncX3-type plasmid among non-clonal Escherichia coli in China

Molecular Epidemiology and Genomic Characterization of a Plasmid-Mediated Mcr-10 and Blandm-1 Co-Harboring Multidrug-Resistant Enterobacter Asburiae.

High Incidence and Endemic Spread of NDM-1-Positive Enterobacteriaceae in Henan Province, China

Exogenous glutathione reverses meropenem resistance in carbapenem-resistant Klebsiella pneumoniae

NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings

Inactivation and photoreactivation of blaNDM-1-carrying super-resistant bacteria by UV, chlorination and UV/chlorination.

Disinfection and mechanism of super-resistant Acinetobacter sp. and the plasmid-encoded antibiotic resistance gene blaNDM-1 by UV/peroxymonosulfate

Evolution of carbapenem resistance in klebsiella pneumoniae and escherichia coli carrying blaNDM−1 gene: imipenem exposure results in sustained resistance memory of strains in vitro

Liposomal Antibiotic Booster Potentiates Carbapenems for Combating NDMs‐Producing Escherichia c oli

A Structural View of the Antibiotic Degradation Enzyme NDM-1 from a Superbug

The effects of NDM-5 on Escherichia coli and the screening of interacting proteins

Complete Genomic Characterization of Two Escherichia Coli Lineages Responsible for a Cluster of Carbapenem-Resistant Infections in a Chinese Hospital

A Natural Novel Mutation in the Bla NDM-5 Promoter Reducing Carbapenems Resistance in a Clinical Escherichia Coli Strain

Dithiocarbamates combined with copper for revitalizing meropenem efficacy against NDM-1-producing Carbapenem-resistant Enterobacteriaceae

Discovery of Thiosemicarbazone Derivatives As Effective New Delhi Metallo-Β-lactamase-1 (NDM-1) Inhibitors Against NDM-1 Producing Clinical Isolates.

Study and prevention of NDM-1-producing superbug

Exogenous NADH promotes the bactericidal effect of aminoglycoside antibiotics against Edwardsiella tarda

A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance

In Vitro Synergistic Activity of Antimicrobial Combinations Against Blakpc and Blandm-Producing Enterobacterales with Blaimp or Mcr Genes

GLO1 Contributes to the Drug Resistance of Escherichia coli Through Inducing PER Type of Extended-Spectrum β-Lactamases